Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 1, 1998, Pages 70-77

  Dana, M Reza ^a,b   Dai, Ruoping ^a   Zhu, Suning ^a   Yamada, Jun ^a   Streilein, J Wayne ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUTERIZATION; CELL MIGRATION; IMMUNE RESPONSE; KERATITIS; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADMINISTRATION, TOPICAL; ANIMALS; ANTERIOR CHAMBER; CELL MOVEMENT; CORNEA; ELECTROCOAGULATION; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; IMMUNITY; IMMUNOSUPPRESSION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; KERATINOCYTES; LANGERHANS CELLS; MICE; MICE, INBRED BALB C; OVALBUMIN; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS;

EID: 0031965280     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Dana MR, Streilein JW. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci 1996;37:2485-2494.
2. Streilein JW. Ocular immune privilege and the Faustian dilemma. The Proctor lecture Invest Ophthalmol Vis Sci 1996;37:1940-1950.
3. Niederkorn JY. Immune privilege and immune regulation in the eye. Adv Immunol. 1990;48:191-226.
4. Mader TH, Stulting RD. The high-risk penetrating keratoplasty Ophthalmol Clin North Am. 1991;4:411-426.
5. Streilein JW, Wilbanks GA, Cousins SW. Immunoregulatory mechanisms of the eye. J Neuroimmunol. 1992;39:185-200.
6. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189-1192.
7. Streilein JW. Anterior chamber associated immune deviation, the privilege of immunity in the eye. [Review]. Surv Ophthalmol. 1990;35:67-73.
8. Cousins SW, Trattler WB, Streilein JW. Immune privilege and suppression of immunogenic inflammation in the anterior chamber of the eye. Curr Eye Res. 1991;10:287-297.
9. Callanan D, Peeler J, Niederkorn JY. Characteristics of rejection of orthotopic corneal allografts in the rat. Transplantation. 1988;45: 437-443.
10. Teunissen MB. Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review, with emphasis on human Langerhans cells. Histochem J. 1992;24:697-716.
11. Steinman RM. Dendritic cells. Transplantation. 1981;31:151-155.
12. Chang CH, Furue M, Tamaki K. Selective regulation of ICAM-1 and major histocompatibiliry complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells. Eur J Immunol. 1994;24: 2889-2895.
13. Jager MJ. Corneal Langerhans cells and ocular immunology. Reg Immunol. 1992;4:186-195.
14. Sano Y, Streilein JW. Effects of suture-induced neovascularization of the cornea on the ocular immunosuppressive microenvironment. Reg Immunol. 1994;6:173-176.
15. Williamson JSP, DiMarco S, Streilein JW. Immunobiology of Langerhans cells on the ocular surface: I. Langerhans cells within the central cornea interfere with induction of anterior chamber associated immune deviation. Invest Ophthalmol Vis Sci. 1987;28: 1527-1532.
16. Streilein JW, Bradley D, Sano Y, Sonoda Y. Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas. Invest Ophthalmol Vis Sci. 1996;37:413-424.
17. Dai R, van RN, Dijkstra CD, Streilein JW. Relative roles of T cells and macrophages in cytokine-mediated functional transformation of cultured splenic dendritic cells. Cell Immunol. 1995;162:265-274.
18. Heufler C, Koch F, Schuler G. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med. 1988;167:700-705.
19. Chang CH, Furue M, Tamaki K. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10. Eur J Immunol. 1995;25:394-398.
20. Niederkorn JY, Peeler JS, Mellon J. Phagocytosis of particulate antigens by corneal epithelial cells stimulates interleukin-1 secretion and migration of Langerhans cells into the central cornea. Reg Immunol. 1989;2:83-90.
21. Staats HF, Lausch RN. Cytokine expression in vivo during murine herpetic stromal keratitis. Effect of protective antibody therapy J Immunol. 1993;151:277-283.
22. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. New Eng J Med. 1993;328:106-113.
23. Le J, Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest. 1987; 56:234-248.
24. De Vos AF, Hoekzema R, Kijlstra A. Cytokines and uveitis, a review. Curr Eye Res. 1992;11:581-597.
25. BenEzra D, Hemo I, Maftzir G. In vivo angiogenic activity of interleukins. Arch Ophthalmol. 1990;108:573-576.
26. Kijlstra A. The role of cytokines in ocular inflammation. Br J Ophthalmol. 1994;78:885-886.
27. West-Mays JA, Strissel KJ, Sadow PM, Fini ME. Competence for collagenase gene expression by tissue fibroblasts requires activation of an interleukin 1 alpha autocrine loop. Proc Natl Acad Sci USA. 1995;92:6768-6772.
28. Shams NB, Reddy CV, Watanabe K, et al. Increased interleukin-1 activity in the injured vitamin A-deficient cornea Cornea. 1994; 13:156-166.
29. Dana MR, Yamada J, Streilein JW. Topical IL-1 receptor antagonist promotes corneal transplant survival. Transplantation. 1997;63: 1501-1507.
30. Collin HB. Ultrastructure of lymphatic vessels in the vascularized rabbit cornea. Exp Eye Res. 1970;10:207-213.
31. Hannum CH, Wilcox CJ, Arend WP, et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 1990;343:336-340.
32. Eisenberg SP, Evans RJ, Arend WP, et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 1990;343:341-346.
33. Antin JH, Weinstein HJ, Guinan EC, et al. Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease. Blood. 1994;84:1342-1348.
34. Abhyankar S, Gilliland DG, Ferrara JL. Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft versus host disease to minor histocompatibility antigens. Transplantation. 1993;56:1518-1523.
35. Dai R, Grammer SF, Streilein JW. Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T cells. J Immunol. 1993;150:59-66.
36. Dai R, Streilein JW. Sensitizing capacity of Langerhans cells obtained from ultraviolet-B-exposed murine skin. Immunology. 1995;86:661-667.
37. Kosiewicz MM, Okamoto S, Miki S, et al. Imposing deviant immunity on the presensitized state. J Immunol. 1994;153:2962-2973.
38. Gillette TE, Chandler JW, Greiner JV. Langerhans cells of the ocular surface. Ophthalmology. 1982;89:700-711.
39. Miki S, Bradley D, Ksander B. IL-12 abrogates immune privilege in the anterior chamber of the eye. Reg Immunol. 1994;6:186-190.
40. Geiger K, Sarvetnick N. Local production of IFN-gamma abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID. J Immunol. 1994;153:5239-5246.
41. Schuler G, Steinman RM. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med. 1985;161:526-546.
42. Cubitt CL, Lausch RN, Oakes JE. Differential regulation of granulocyte-macrophage colony-stimulating factor gene expression in human corneal cells by pro-inflammatory cytokines. J Immunol. 1994;153:232-240.
43. Enk AH, Angeloni VL, Udey MC, Katz SI. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. J Immunol. 1993;150:3698-3704.
44. Ariizumi K, Kitajima T, Bergstresser OR, Takashima A. Interleukin-1 beta converting enzyme in murine Langerhans cells and epidermal-derived dendritic cell lines. Eur J Immunol. 1995;25: 2137-2141.
45. Weiss JM, Sleeman J, Renkl AC, et al. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J Cell Biol. 1997;137:1137-1147.
46. Austyn JM. New insights into the mobilization and phagocytic activity of dendritic cells. J Exp Med. 1996;183:1287-1292.
47. Mugridge KG, Perretti M, Ghiara P, Parente L. Alpha-melanocyte-stimulating hormone reduces interleukin-1 beta effects on rat stomach preparations possibly through interference with a type I receptor. Eur J Pharmacol. 1991;197:151-155.
48. Cannon JG, Tatro JB, Reichlin S, Dinarello CA. Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J Immunol. 1986;137:2232-2236.
49. Watanabe T, Hiltz ME, Catania A, Lipton JM. Inhibition of IL-1 beta-induced peripheral inflammation by peripheral and central administration of analogs of the neuropeptide alpha-MSH. Brain Res Bull. 1993;32:311-314.
50. van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB. In vivo protection against interleukin-1-induced articular cartilage damage by transforming growth factor-beta 1: age-related differences. Ann Rheumatic Dis. 1994;53:593-600.
51. Fleisher LN, McGahan MC, Ferrell JB, Pagan I. Interleukin-1 beta increases prostaglandin E2-stimulated adenosine 3′,5′-cyclic monophosphate production in rabbit pigmented ciliary epithelium. Exp Eye Res. 1996;63:91-104.
52. Barnum SR, Jones JL. Transforming growth factor-beta 1 inhibits inflammatory cytokine-induced C3 gene expression in astrocytes. J Immunol. 1994;152:765-773.
53. Pronost S, Segond N, Macro M, et al. Modulation of interleukin-1 receptor expression by transforming growth factor-beta in cultured rabbit articular chondrocytes: analysis by reverse transcription-polymerase chain reaction. Osteoarthritis & Cartilage. 1995; 3:147-155.
54. Taylor AW. Neuroimmunomodulation in immune privilege: role of neuropeptides in ocular immunosuppression. Neuroimmunomodulation. 1996;3:195-204.
55. Friedlander RM, Gagliardini V, Rotello RJ, Yuan J. Functional role of interleukin 1 beta (IL-1 beta) in IL-1 beta-converting enzyme-mediated apoptosis. J Exp Med. 1996;184:717-724.